Rare diseases
Investigational molecules
Locations
Back to Germany1 118 clinical trials in Sankt Augustin, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
GermanyStudy on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy
GermanyStudy on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus
GermanyStudy on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease
GermanyStudy on the Safety and Effectiveness of Dazucorilant for Patients with Amyotrophic Lateral Sclerosis (ALS)
GermanyGermanyFirst-line treatment of metastatic non‑small cell lung cancer with high PD‑L1 expression: ivonescimab versus pembrolizumab
GermanyZenagamtide versus semaglutide: a study of blood sugar and weight reduction in adults with type 2 diabetes inadequately controlled on metformin and/or SGLT2 inhibitor
GermanyPhase 3 Study of Subcutaneous vs Intravenous Tarlatamab with Siltuximab in Relapsed Extensive-Stage Small Cell Lung Cancer after Platinum Chemotherapy
GermanyPhase 3 Study of GSK6042981 versus Imatinib in Adults with Previously Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)
GermanyComparing Daraxonrasib Alone or Combined with Gemcitabine and Paclitaxel Albumin‑Bound vs Standard Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma
GermanyLong-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on innovative treatments for juvenile arthritis conditions, including studies of medications like baricitinib, ustekinumab, and bimekizumab for various forms of JIA.
Research aims to evaluate drug efficacy and safety in pediatric populations with autoimmune conditions.
Comprehensive studies on childhood cancers, with particular focus on leukemia and lymphoma treatments, including novel therapeutic approaches and combination therapies.
Investigations include targeted therapies and personalized treatment protocols for various cancer stages.
Specialized research into brain and nervous system tumors, focusing on ependymoma and medulloblastoma treatment strategies.
Studies evaluate surgical outcomes, radiation therapy approaches, and chemotherapy effectiveness.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
